Separate current trading from historical accounts
The latest selected financial period is 2018-09-30. A recent market quote or a new scoring timestamp does not update those accounts.
—
—
—
Cannara Biotech
—
—
Live Price
CIN RESEARCH · DATED EVIDENCE
Historical financial evidenceCannara Biotech: newer financial reporting is the missing piece.
The available financial series reaches September 30, 2018; current financial conclusions are withheld.
Latest financial observation 2018-09-30Price history through 2019-02-22Research checked 2026-11-07 13:30 UTC
The check time records a research refresh. Each financial figure and price keeps its own reporting date.
Reported financial evidence
| Measure | Reported value & unit | Period & interval | Evidence basis |
|---|---|---|---|
| RevenueHistorical observation | CAD 12.59mUnit: CAD | Quarterly series | Dated financial series |
| Cost of revenueHistorical observation | CAD 50,000Unit: CAD | Quarterly series | Dated financial series |
| Gross profitHistorical observation | CAD 12.54mUnit: CAD | Quarterly series | Dated financial series |
| Operating incomeHistorical observation | CAD 1.15mUnit: CAD | Quarterly series | Dated financial series |
| Net incomeHistorical observation | CAD 421,000Unit: CAD | Quarterly series | Dated financial series |
| Cash balanceHistorical observation | CAD 5.42mUnit: CAD | Balance at period end | Dated financial series |
| Total assetsHistorical observation | CAD 211.02mUnit: CAD | Balance at period end | Dated financial series |
| Total liabilitiesHistorical observation | CAD 23.54mUnit: CAD | Balance at period end | Dated financial series |
| Shareholders’ equityHistorical observation | CAD 187.49mUnit: CAD | Balance at period end | Dated financial series |
| Operating cash flowHistorical observation | CAD -3.99mUnit: CAD | Quarterly series | Dated financial series |
A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.
What to investigate next
- Locate a newer primary financial report and reconcile its units before making a current company assessment.
Evidence boundaries
- The newest available revenue observation is historical on its supplied reporting basis. A current revenue assessment is withheld.
- No dated primary company disclosures were supplied; absence in this feed is not a clean regulatory check.
- Interim frequency is provider-classified. Generic form labels are not treated as proof of an SEC filing or a three-month reporting duration.
- The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.
Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →
Price History · currency not supplied
5 Years
Fundamentals
SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
CONTINUE YOUR RESEARCH